Smoking-Cessation Efforts by US Adult Smokers with Medical Comorbidities - 22/11/17
Abstract |
Background |
Continued cigarette smoking by individuals with chronic medical diseases can adversely affect their symptoms, disease progression, and mortality. We assessed the association between medical comorbidities and smoking-cessation efforts among US adult smokers.
Methods |
We analyzed cross-sectional data from 12,494 past-year cigarette smokers aged ≥18 years from Wave 1 (2013-2014) of the nationally representative Population Assessment of Tobacco and Health study. We assessed the association between self-reported medical comorbidities and past-year quit attempts, use of evidence-based smoking-cessation treatment or electronic cigarettes, and successful smoking cessation using logistic regression, adjusting for sociodemographics, insurance status, geographic region, and having a past-year doctor visit.
Results |
In the study sample, 39% were aged 18 to 34 years, 45% were female, 70% were non-Hispanic white, and 48% reported ≥1 comorbidity. Smokers with any comorbidity, compared with those without comorbidities, had higher odds of trying to quit (adjusted odds ratio, 1.19; 95% confidence interval, 1.08-1.30), but no higher likelihood of quitting success. Having more medical comorbidities was associated with increased odds of trying to quit. Smokers with a comorbidity used evidence-based treatment more often than smokers without comorbidities (43% vs 26%); use of e-cigarettes to quit was similar between smokers with and without comorbidities (27% vs 28%).
Conclusions |
Adult smokers with chronic medical diseases try to quit and use evidence-based tobacco-cessation treatment more often than smokers without comorbidities, but they are no more likely to quit, suggesting that their quit attempts are less likely to succeed. Smokers with medical comorbidities may require more intensive, prolonged, and repeated treatment to stop smoking.
Le texte complet de cet article est disponible en PDF.Keywords : Electronic cigarettes, Smoking cessation, Tobacco treatment
Plan
Funding: This work was funded by Carney Family Foundation award to SK. The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. |
|
Conflicts of Interest: SK receives royalties from UpToDate for authorship of a topic review on e-cigarettes. GRK has a family financial interest in Dimagi and is a paid consultant for Click Therapeutics. NAR has a research grant from and has consulted without pay for Pfizer regarding smoking cessation, and she receives royalties from UpToDate for authorship of topic reviews on smoking cessation and e-cigarettes. |
|
Authorship: All authors had access to the data and played a role in writing this manuscript. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?